Acquisition by Alam Kamran of 431000 shares of Taysha Gene at 1.85 subject to Rule 16b-3
| MOBO Stock | USD 0.0001 0.00 0.00% |
About 65% of Mobile Lads' investor base is looking to short. The analysis of overall sentiment of trading Mobile Lads Corp pink sheet suggests that many investors are alarmed at this time. Mobile Lads' investing sentiment overview a quick insight into current market opportunities from investing in Mobile Lads Corp. Many technical investors use Mobile Lads Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Mobile |
Filed transaction by Taysha Gene Therapies Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Mobile Lads Fundamental Analysis
We analyze Mobile Lads' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mobile Lads using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mobile Lads based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Mobile Lads is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Mobile Lads Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mobile Lads pink sheet to make a market-neutral strategy. Peer analysis of Mobile Lads could also be used in its relative valuation, which is a method of valuing Mobile Lads by comparing valuation metrics with similar companies.
Peers
Mobile Lads Related Equities
| ZVSA | ZyVersa Therapeutics | 7.86 | ||||
| IMMX | Immix Biopharma | 3.54 | ||||
| PALI | Palisade Bio | 3.50 | ||||
| AFMD | Affimed NV | 0.91 | ||||
| AKBA | Akebia Ther | 0.84 | ||||
| ABEO | Abeona Therapeutics | 0.19 | ||||
| GLMD | Galmed Pharmaceuticals | 0.34 | ||||
| ITOS | Iteos Therapeutics | 0.39 | ||||
| TSHA | Taysha Gene | 0.65 | ||||
| ANNX | Annexon | 2.59 | ||||
| UNCY | Unicycive Therapeutics | 4.76 |
Other Information on Investing in Mobile Pink Sheet
Mobile Lads financial ratios help investors to determine whether Mobile Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mobile with respect to the benefits of owning Mobile Lads security.